
Ekso Bionics Holdings EKSO
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
139 M |
Market Cap[1] |
$ 28.6 M |
EBITDA (LTM) |
$ 22.8 M |
P/E (LTM) |
- |
P/S (LTM) |
0.399793 |
EPS (LTM) |
-0.36 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
$ 38.61 | 3.51 % | $ 1.84 B | Nasdaq Global Select Market | ||
|
Alcon
ALC
|
$ 72.29 | -2.39 % | $ 35.7 B | NYSE | ||
|
electroCore
ECOR
|
$ 7.74 | 0.26 % | $ 65.7 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 449.23 | -0.18 % | $ 160 B | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 62.93 | -1.01 % | $ 12.5 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.55 | 0.04 % | $ 16.5 M | NYSE American | ||
|
STERIS plc
STE
|
$ 256.26 | -0.35 % | $ 25.2 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 73.41 | 0.75 % | $ 238 M | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 9.77 | 0.72 % | $ 1.95 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 15.0 | -1.83 % | $ 310 M | NYSE American | ||
|
iRhythm Technologies
IRTC
|
$ 88.65 | 3.01 % | $ 2.84 B | Nasdaq Global Select Market,SPB | ||
|
OraSure Technologies
OSUR
|
$ 3.55 | 6.61 % | $ 261 M | Nasdaq Global Select Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 26.41 | 10.64 % | $ 1.31 B | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Teleflex Incorporated
TFX
|
$ 155.91 | 0.55 % | $ 6.96 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 213.53 | 0.4 % | $ 61.4 B | NYSE,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 413.04 | 0.12 % | $ 29.9 B | NYSE,SPB | ||
|
Baxter International
BAX
|
$ 26.37 | -0.15 % | $ 13.5 B | NYSE,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.73 | 17.88 % | $ 172 M | Nasdaq Capital Market | ||
|
AtriCure
ATRC
|
$ 57.54 | 2.28 % | $ 2.75 B | Nasdaq Global Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 12.41 | 2.82 % | $ 515 M | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 246.34 | 4.15 % | $ 14.1 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 9.81 | 5.94 % | $ 435 M | Nasdaq Global Market | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Microbot Medical
MBOT
|
$ 1.11 | 5.71 % | $ 50.8 M | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 120.49 | -1.58 % | $ 5.68 B | NYSE,SPB | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
ICU Medical
ICUI
|
$ 178.32 | -2.15 % | $ 4.39 B | Nasdaq Global Select Market,SPB | ||
|
ResMed
RMD
|
$ 238.38 | 1.81 % | $ 34.7 B | NYSE,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.31 | 1.7 % | $ 25.4 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 88.19 | 0.43 % | $ 5.22 B | Nasdaq Global Select Market,SPB | ||
|
Nephros
NEPH
|
$ 3.09 | -2.06 % | $ 32.8 M | Nasdaq Global Select Market | ||
|
Pro-Dex
PDEX
|
$ 71.2 | 1.92 % | $ 230 B | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 25.33 | -1.99 % | $ 4.26 B | NYSE | ||
|
LeMaitre Vascular
LMAT
|
$ 79.26 | 0.3 % | $ 1.79 B | Nasdaq Global Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 56.65 | 2.77 % | $ 3.82 B | Nasdaq Global Select Market | ||
|
Repligen Corporation
RGEN
|
$ 172.96 | -0.59 % | $ 9.73 B | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Stereotaxis
STXS
|
$ 0.9 | -12.63 % | $ 81.9 M | NYSE American | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.